| Name: | Pharmaceutical Technologies, Inc. |
| Jurisdiction: | MISSISSIPPI |
| Business Type: | Profit Corporation |
| Status: | Withdrawn |
| Effective Date: | 09 Jan 2014 (11 years ago) |
| Business ID: | 1033896 |
| State of Incorporation: | NEBRASKA |
| Principal Office Address: | 13660 California StreetOmaha, NE 68154 |
| Historical names: |
CastiaRx |
| Name | Role | Address |
|---|---|---|
| C. T. CORPORATION SYSTEM | Agent | 645 LAKELAND EAST DRIVE STE 101, FLOWOOD, MS 39232 |
| Name | Role | Address |
|---|---|---|
| Peter Marshall Gill | Treasurer | 9900 Bren Road East, Minnetonka, MN 55343 |
| Name | Role | Address |
|---|---|---|
| Karen Elizabeth Peterson | Secretary | 1600 McConnor Parkway, Schaumburg, IL 60173 |
| Name | Role | Address |
|---|---|---|
| Michael Gerard Zeglinski | Director | 1600 McConnor Parkway, Schaumburg, IL 60173 |
| Name | Role | Address |
|---|---|---|
| Michael Gerard Zeglinski | President | 1600 McConnor Parkway, Schaumburg, IL 60173 |
| Type | Status | Filed Date | Description |
|---|---|---|---|
| Withdrawal | Filed | 2023-02-21 | Withdrawal For Pharmaceutical Technologies, Inc. |
| Annual Report | Filed | 2022-04-14 | Annual Report For Pharmaceutical Technologies, Inc. |
| Merger | Filed | 2021-12-20 | Merger For Pharmaceutical Technologies, Inc. |
| Merger | Rejected | 2021-12-17 | Merger For Pharmaceutical Technologies, Inc. |
| Annual Report | Filed | 2021-04-06 | Annual Report For Pharmaceutical Technologies, Inc. |
| Amendment Form | Filed | 2020-08-04 | Amendment For Pharmaceutical Technologies, Inc. |
| Annual Report | Filed | 2020-03-14 | Annual Report For Pharmaceutical Technologies, Inc. |
| Annual Report | Filed | 2019-04-09 | Annual Report For Pharmaceutical Technologies, Inc. |
| Amendment Form | Filed | 2018-05-15 | Amendment For Pharmaceutical Technologies, Inc. |
| Fictitious Name Registration | Filed | 2018-04-03 | Fictitious Name Registration For Pharmaceutical Technologies, Inc. |
Date of last update: 10 Jan 2025
Sources: Mississippi Secretary of State
